These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6978499)

  • 1. Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients.
    Smith J; Heelan RT; Huvos AG; Caparros B; Rosen G; Urmacher C; Caravelli JF
    Radiology; 1982 May; 143(2):355-60. PubMed ID: 6978499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telangiectatic osteosarcoma: unusual behaviour.
    Chowdhury K; Bachynski B; Alport EC
    Can J Surg; 1986 Jan; 29(1):29-31. PubMed ID: 3455674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for primary osteogenic sarcoma.
    Cortes EP; Holland JF
    Surg Clin North Am; 1981 Dec; 61(6):1391-404. PubMed ID: 6976008
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
    Lange B; Kramer S; Gregg JR; Toledano S; Wimmer R; Evans AE
    Am J Clin Oncol; 1982 Feb; 5(1):3-8. PubMed ID: 6979238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients.
    Huvos AG; Rosen G; Bretsky SS; Butler A
    Cancer; 1982 Apr; 49(8):1679-89. PubMed ID: 6950802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate in osteogenic sarcoma.
    Jaffe N; Link MP; Cohen D; Traggis D; Frei E; Watts H; Beardsley GP; Abelson HT
    Natl Cancer Inst Monogr; 1981 Apr; (56):201-6. PubMed ID: 6975438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
    Rosen G; Marcove RC; Huvos AG; Caparros BI; Lane JM; Nirenberg A; Cacavio A; Groshen S
    J Cancer Res Clin Oncol; 1983; 106 Suppl():55-67. PubMed ID: 6604058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis.
    Ahuja SC; Villacin AB; Smith J; Bullough PG; Huvos AG; Marcove RC
    J Bone Joint Surg Am; 1977 Jul; 59(5):632-47. PubMed ID: 267053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Juxtacortical osteogenic sarcoma localized in the hand. Presentation of 2 cases].
    Rombouts J-J ; Noël H
    Rev Chir Orthop Reparatrice Appar Mot; 1975; 61(1):75-86. PubMed ID: 124072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Course of metastatic osteogenic sarcoma treated with chemotherapy only (author's transl)].
    Tröger J; Gutjahr P
    Arch Orthop Trauma Surg (1978); 1979 Apr; 93(4):315-7. PubMed ID: 313774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteosarcoma of the diaphysis of long bones: clinicopathologic features and treatment of 51 cases.
    Sim FH; Frassica FJ; Unni KK
    Orthopedics; 1995 Jan; 18(1):19-23. PubMed ID: 7899164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the treatment of osteosarcoma.
    Chang P
    Med Clin North Am; 1977 Sep; 61(5):1027-38. PubMed ID: 408567
    [No Abstract]   [Full Text] [Related]  

  • 16. Telangiectatic osteogenic sarcoma. A review of twenty-eight cases.
    Farr GH; Huvos AG; Marcove RC; Higinbotham NL; Foote FW
    Cancer; 1974 Oct; 34(4):1150-8. PubMed ID: 4529332
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.
    Huvos AG; Rosen G; Marcove RC
    Arch Pathol Lab Med; 1977 Jan; 101(1):14-8. PubMed ID: 299812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of orbital osteogenic sarcoma.
    Trevisani MG; Fry CL; Hesse RJ; Willis GW
    Arch Ophthalmol; 1996 Apr; 114(4):494-5. PubMed ID: 8602795
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
    Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.